Skip to main content
LEAP THERAPEUTICS, INC. logo

LEAP THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LPTX ISIN · US52187K2006 LEI · 549300T31SMMJ2DDLI13 US Manufacturing
Open in API
Filings indexed 584 across all filing types
Latest filing 2020-08-13 Earnings Release
Country US United States of America
Listing US LPTX

About LEAP THERAPEUTICS, INC.

https://www.leaptx.com/

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer. Its most advanced clinical candidate, DKN-01 (sirexatamab), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, being developed for patients with esophagogastric, gynecologic, and colorectal cancers. The company's pipeline also includes FL-301, a monoclonal antibody targeting Claudin18.2 for gastric and pancreatic cancer, and FL-501, a preclinical antibody targeting the growth and differentiation factor 15 (GDF-15) protein.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 13, 2020, by Leap Therapeutics, Inc. It announces the company's financial results for the quarter ended June 30, 2020, and includes a press release as an exhibit. The text explicitly states that the press release is furnished as an exhibit and that the information is not incorporated by reference into other filings. The document length is 4294 characters, which is relatively short and consistent with a current report or announcement rather than a full financial report. The content is primarily an announcement of quarterly financial results rather than the detailed financial statements or analysis found in an Interim/Quarterly Report (IR). Therefore, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2020-08-13 English
FORM 10-Q
Interim / Quarterly Report Q2 2020
2020-08-13 English
4
Director's Dealing
2020-08-13 English
4
Director's Dealing
2020-08-13 English
4
Director's Dealing
2020-08-13 English
4
Director's Dealing
2020-08-13 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.